Clorox (CLX) Set to Announce Earnings on Tuesday

Clorox (NYSE:CLXGet Free Report) will be releasing its earnings data after the market closes on Tuesday, April 30th. Analysts expect Clorox to post earnings of $1.34 per share for the quarter. Clorox has set its FY24 guidance at $5.30-5.50 EPS and its FY 2024 guidance at 5.300-5.500 EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The business’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.98 EPS. On average, analysts expect Clorox to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Clorox Price Performance

Shares of NYSE:CLX opened at $146.48 on Friday. The company’s fifty day moving average price is $149.39 and its 200-day moving average price is $142.60. The firm has a market capitalization of $18.18 billion, a price-to-earnings ratio of 232.51, a PEG ratio of 2.33 and a beta of 0.43. Clorox has a one year low of $114.68 and a one year high of $178.21. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s payout ratio is 761.92%.

Analyst Ratings Changes

A number of brokerages have recently commented on CLX. Citigroup decreased their price target on shares of Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a report on Tuesday, April 16th. UBS Group increased their target price on shares of Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. DA Davidson reaffirmed a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Barclays reduced their target price on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $148.63.

View Our Latest Stock Report on Clorox

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Earnings History for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.